Next available appointment
Toll Free Booking Helpline
GPs available on standby
On 16 June 2020, ResApp signed a two-year, non-exclusive commercial software licensing agreement with Phenix Health Pty Ltd, Australia based virtual super clinic, to use
ResApp Health Sign Software Licensing Agreement with Phenix Health On 16 June 2020, ResApp and Phenix Health signed a licensing deal for employing ResAppDx-EU in
ASX listed digital health company ResApp has signed a memorandum of understanding with health products manufacturer RB, formerly known as Reckitt Benckiser, to develop a
Cough monitor Resapp (ASX:RAP) has done a deal with telehealth company Phenix Health, following a similar deal by Respiri (ASX:RSH) in April. The software licensing agreement for its ResAppDX-EU
Respiri’s agreement with the Pharmacy Guild of Australia will build awareness and knowledge of its wheeze respiratory evaluation device and technology. Respiri has already secured
The average GP consultation take about six minutes. That figure is very significant in the context of the two-year, non-exclusive commercial software licensing agreement Resapp
In March, ResApp announced to have completed the initial integration of ResAppDx-EU into Coviu’s telehealth platform and that ResApp and Coviu had agreed upon a
Wheezo asthma diagnostic and monitoring technology Respiri has developed its wheezo device and eHealth software as a service technology to support the management of respiratory